Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 15
2003 11
2004 7
2005 8
2006 9
2007 9
2008 9
2009 16
2010 17
2011 19
2012 17
2013 19
2014 16
2015 19
2016 18
2017 14
2018 12
2019 14
2020 8
2021 8
2022 4
2023 6
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

247 results

Results by year

Filters applied: . Clear all
Page 1
Neoadjuvant Chemotherapy in High-Risk Soft Tissue Sarcomas: Final Results of a Randomized Trial From Italian (ISG), Spanish (GEIS), French (FSG), and Polish (PSG) Sarcoma Groups.
Gronchi A, Palmerini E, Quagliuolo V, Martin Broto J, Lopez Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz Beveridge R, Ferraresi V, Lugowska I, Merlo DF, Fontana V, Marchesi E, Braglia L, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Casali PG. Gronchi A, et al. Among authors: coindre jm. J Clin Oncol. 2020 Jul 1;38(19):2178-2186. doi: 10.1200/JCO.19.03289. Epub 2020 May 18. J Clin Oncol. 2020. PMID: 32421444 Clinical Trial.
Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study.
Italiano A, Soria JC, Toulmonde M, Michot JM, Lucchesi C, Varga A, Coindre JM, Blakemore SJ, Clawson A, Suttle B, McDonald AA, Woodruff M, Ribich S, Hedrick E, Keilhack H, Thomson B, Owa T, Copeland RA, Ho PTC, Ribrag V. Italiano A, et al. Among authors: coindre jm. Lancet Oncol. 2018 May;19(5):649-659. doi: 10.1016/S1470-2045(18)30145-1. Epub 2018 Apr 9. Lancet Oncol. 2018. PMID: 29650362 Clinical Trial.
Pleomorphic Sarcomas: The State of the Art.
Carvalho SD, Pissaloux D, Crombé A, Coindre JM, Le Loarer F. Carvalho SD, et al. Among authors: coindre jm. Surg Pathol Clin. 2019 Mar;12(1):63-105. doi: 10.1016/j.path.2018.10.004. Epub 2018 Dec 17. Surg Pathol Clin. 2019. PMID: 30709449 Review.
Well-differentiated and dedifferentiated liposarcomas.
Coindre JM, Pédeutour F, Aurias A. Coindre JM, et al. Virchows Arch. 2010 Feb;456(2):167-79. doi: 10.1007/s00428-009-0815-x. Epub 2009 Aug 18. Virchows Arch. 2010. PMID: 19688222 Review.
[Molecular biology for sarcoma: useful or necessary?].
Neuville A, Coindre JM, Chibon F. Neuville A, et al. Among authors: coindre jm. Ann Pathol. 2015 Jan;35(1):107-13. doi: 10.1016/j.annpat.2014.11.004. Epub 2014 Dec 20. Ann Pathol. 2015. PMID: 25533919 Review. French.
Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.
Pasquali S, Palmerini E, Quagliuolo V, Martin-Broto J, Lopez-Pousa A, Grignani G, Brunello A, Blay JY, Tendero O, Diaz-Beveridge R, Ferraresi V, Lugowska I, Infante G, Braglia L, Merlo DF, Fontana V, Marchesi E, Donati DM, Palassini E, Bianchi G, Marrari A, Morosi C, Stacchiotti S, Bagué S, Coindre JM, Dei Tos AP, Picci P, Bruzzi P, Miceli R, Casali PG, Gronchi A. Pasquali S, et al. Among authors: coindre jm. Cancer. 2022 Jan 1;128(1):85-93. doi: 10.1002/cncr.33895. Epub 2021 Oct 13. Cancer. 2022. PMID: 34643947 Free article. Clinical Trial.
[Primary adrenal angiosarcoma].
Galmiche L, Morel HP, Moreau A, Labrosse PA, Coindre JM, Heymann MF. Galmiche L, et al. Among authors: coindre jm. Ann Pathol. 2004 Sep;24(4):371-3. doi: 10.1016/s0242-6498(04)93987-9. Ann Pathol. 2004. PMID: 15567956 Review. French.
247 results